Press releases
Quotient Limited Provides First Quarter Fiscal 2023 Results and Business Update
JERSEY, Channel Islands, August 9, 2022 (GLOBE NEWSWIRE) – Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today reported its first quarter fiscal 2023 key financial results and provided an update on recent…
Quotient Limited to Report First Quarter Fiscal 2023 Financial Results and Host Conference Call on August 9th
Quotient Limited and InfYnity Biomarkers Announce Partnership to Expand MosaiQ Infectious Disease Menu
- Partnership aims to expand the Transfusion Transmissible Infections, other Infectious Diseases, and clinical diagnostics assay menu on Quotient’s multimodality, multiplexed MosaiQ solution
Quotient Limited Announces Equity Awards
Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares and Pre-Funded Warrants
Quotient Limited Provides Fourth Quarter Fiscal 2022 Results and Business Update
Quotient Limited Announces Pricing of Underwritten Offering
Quotient Limited Announces Proposed Underwritten Offering
Quotient Limited Announces Proposed Amendments to Senior Secured Notes
Quotient Limited Reschedules Fourth Quarter and Full Year 2022 Financial Results Announcement to Friday, June 24th and Provides a Preview of Financials
• Pre-announces FY 2022 revenue of $38.5 million

• Secured $1.4 million of orders in Q1 FY23 for recently CE Marked Extended IH MosaiQ Solution

• $83.2 million in cash and investments as of March 31, 2022